US House Judiciary Committee votes in favour of the Preserve Access to Affordable Generics and Biosimilars Act

Sep 29, 2021

The US House Judiciary Committee voted in favour of the Preserve Access to Affordable Generics and Biosimilars Act. If passed, this act would allow the FTC to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connected with the sale of a drug or biological product.

Print Page Mail Article